FDA approves Moderna’s mRNA-based flu vaccine

FDA approves Moderna’s mRNA-based flu vaccine

WASHINGTON (AP) — The Food and Drug Administration has approved a new kind of flu vaccine for older people, the first made with the same mRNA technology that was key to ending the COVID-19 pandemic, manufacturer Moderna said. The shot, named mFlusiva, is intended for adults age 50 or older. Other brands of flu shots already have begun arriving … Read more

FDA approves Moderna’s next-generation COVID vaccine for adults 65 or older

FDA approves Moderna’s next-generation COVID vaccine for adults 65 or older

The US Food and Drug Administration has approved Moderna’s next-generation COVID-19 vaccine for everyone aged 65 and above, the company said on Saturday, the first endorsement since the regulator tightened requirements. The vaccine has also been approved for people aged 12 to 64 with at least one or more underlying risk factors defined by the … Read more